Generated August 15, 2026.
Figures quoted in this analysis are from its generation date and may lag the live snapshot table above, which always shows the latest data.
Overview
CHPY and EGGY are both equity ETFs that generate income through covered-call options strategies on U.S. equities. CHPY focuses on a semiconductor basket with a weekly distribution cadence and a 39.75% distribution rate, while EGGY targets large-cap stocks aligned with the Nasdaq 100 on a monthly schedule with a 32.72% distribution rate. Both are synthetic-income products that trade principal preservation for high current yield.
How they differ
The biggest difference is sector focus: CHPY concentrates on semiconductor equities and writes calls on both its holdings and semiconductor ETFs, while EGGY holds a broader Nasdaq 100–aligned basket. CHPY's weekly distribution frequency contrasts with EGGY's monthly payouts, and CHPY's 39.75% yield significantly exceeds EGGY's 32.72%, though that gap comes with higher volatility—CHPY's beta of 1.86 is materially higher than EGGY's 1.61. On fees, EGGY edges lower at 0.92% versus CHPY's 1.03%, and EGGY's $148 million AUM is substantially smaller than CHPY's $1.08 billion, suggesting CHPY has attracted more capital but both remain relatively young (CHPY since April 2025, EGGY since December 2024).
Who each is best for
- CHPY: Fits investors seeking aggressive current income who have conviction in semiconductor valuations and can tolerate the combination of high beta exposure and the NAV erosion risk that typically accompanies yields above 35%.
- EGGY: Designed for income-focused investors who prefer exposure to a diversified large-cap growth basket (Nasdaq 100) over single-sector concentration, and who prioritize lower volatility and slightly lower fees in exchange for accepting a more modest yield target.
Key risks to know
- NAV erosion at extreme yield levels. CHPY's 39.75% annualized distribution rate substantially exceeds typical equity total returns and suggests meaningful capital return and/or NAV decay over time. EGGY's 32.72% yield carries the same structural risk, though to a lesser degree.
- Semiconductor sector concentration. CHPY's basket holding plus call writing on semiconductor equities and sector ETFs creates single-industry exposure; a downturn in chip stocks or cyclical weakness in semiconductor demand creates compounded drawdown risk. EGGY's Nasdaq 100 tilt still carries tech-sector sensitivity, though with broader diversification.
- Elevated volatility and downside amplification. CHPY's beta of 1.86 and EGGY's 1.61 indicate these funds will decline faster than the broad market in downturns. The leverage embedded in options strategies can amplify losses when underlying equities fall sharply, offsetting the income cushion during rallies.
- Call cap risk and upside sacrifice. Both funds write covered calls to generate premium; in strong bull markets or individual stock surges, capped gains reduce total return, which may reduce long-term NAV support for distributions.
- Liquidity and AUM concentration. EGGY's $148 million AUM is quite small for an ETF; redemption pressure or outflows could widen spreads and reduce trading liquidity relative to CHPY's larger base.
Bottom line
CHPY offers higher current yield in exchange for single-sector concentration and higher volatility; EGGY provides broader equity diversification and lower beta at the cost of a smaller income stream and substantially smaller fund size. Both strategies rely on options premiums to sustain yields that exceed historical equity returns, raising the likelihood of NAV decline over multi-year horizons. If you prioritize maximum income and have a high risk tolerance, CHPY's semiconductor focus may appeal; if you want diversified large-cap exposure with a more moderate yield, EGGY's structure is less volatile. Past performance does not predict future results, and the sustainability of distributions at these levels warrants careful monitoring.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.